AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Evaluation of Pulsed Field Ablation of the Posterior Nasal Nerve for Chronic Rhinitis

RecruitingNAAges 18 Years - 85 YearsAllAventix Medical Inc.
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Evaluation of safety, effectiveness and tolerability of the Aventix Medical Device used for the treatment of chronic rhinitis

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: 1. The subject is 18 to 85 years of age. 2. The subject has had symptoms of chronic rhinitis for greater than 6 months with insufficient response to nasal steroids. 3. The subject has an rTNSS total score of โ‰ฅ 6. 4. The subject has had moderate to severe symptoms of rhinorrhea and/or nasal congestion (rTNSS rating of 2 or 3 for rhinorrhea and 1, 2, or 3 for congestion) 5. The subject is able and willing to provide written informed consent and comply with the protocol requirements. Exclusion Criteria: 1. The subject has clinically significant anatomic obstructions on either side that limit access to the posterior nose, including severe septal deviation, nasal polyps, and sinonasal tumor 2. The subject has a septal perforation 3. The subject has had prior sinus or nasal surgery on either side that significantly alters the anatomy of the posterior nose. 4. The subject had had previous surgery of the PNN for chronic rhinitis. 5. The subject has had prior head or neck irradiation 6. The subject has an active or chronic nasal or sinus infection 7. The subject has active coagulation disorder, or the patient is receiving anticoagulants 8. The subject has a history of dry eye or dry nose symptoms 9. Patient has rhinitis medicamentosa 10. The subject has ocular allergic symptoms 11. The subject has a history of nose bleeds 12. The subject has electrically sensitive implants (e.g. cochlear implants, pacemakers, defibrillators) 13. The subject is pregnant or lactating 14. The subject is participating in another clinical research study 15. The subject has an allergy or intolerance to anesthetic agent 16. Any physical condition that, in the Investigator's opinion, would prevent adequate study participation or pose an increased risk
๐Ÿ’Š

What it tests

  • NOVOCLEARโ„ข Device
๐Ÿ“

Where

3 sites
Colorado ENT and Allergy
Colorado Springs, United States
Bay Area ENT
Ocean Springs, United States
Atkins Expert Sinus Care
San Antonio, United States
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy